PHAR News and Press, Pharming Group N.V. From 09/22/23

2023-09-22 12:52:13 ET For further details see: CETX, MYO and MORF among mid-day movers

2023-09-22 09:59:56 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecuti...

2023-09-09 12:30:37 ET Summary Pharming Group NV is a biotechnology firm known for its unique approach to addressing rare and genetic diseases. The company's financials show growth in revenue, primarily driven by strong sales of their leading therapy, Ruconest. Pharming's expa...

Pharming Group to participate in September investor conferences PR Newswire LEIDEN, The Netherlands , Aug. 24, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participat...

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan PR Newswire Single-arm Phase III study in Japan evaluating leniolisib in patients aged 12 years and older with APDS, a rare primary immunodeficiency ...

2023-08-06 04:51:08 ET Pharming Group N.V. (PHAR) Q2 2023 Earnings Conference Call August 03, 2023 07:30 AM ET Company Participants Sijmen de Vries - Executive Director and Chief Executive Officer Anurag Relan - Chief Medical Officer Stephen Toor - Chief Commerci...

2023-08-06 02:54:01 ET Pharming Group N.V. (PHGUF) Q2 2023 Earnings Conference Call August 03, 2023 07:30 AM ET Company Participants Sijmen de Vries - CEO Anurag Relan - CMO Stephen Toor - CCO Jeroen Wakkerman - CFO Conference Call Participants Ch...

Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board PR Newswire LEIDEN, The Netherlands , July 18, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today tha...

Pharming Group to report second quarter and first half 2023 financial results on August 3 PR Newswire LEIDEN, The Netherlands , July 13, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its pre...

2023-06-01 10:44:12 ET Pharming Group ( NASDAQ: PHAR ) has entered into a definitive agreement with Novartis Pharma A.G. to sell its Rare Pediatric Disease Priority Review Voucher, the company said Thursday. Under sale terms, Novartis has pre-agreed to a one-time payment...